Roper Technologies (ROP) Stock Faces One Off $1.1b Gain Driving EPS Surge

Roper Technologies (ROP) has delivered a headline grabbing quarter, with Q2 2026 revenue at US$2.1 billion and basic EPS of US$11.64. This feeds into trailing 12 month figures of US$8.3 billion in revenue and EPS of US$23.90, which sit alongside a reported 62.7% earnings lift and a net margin of 30.2% over the past year. The company has seen quarterly revenue move from US$1,943.6 million in Q2 2025 to US$2,108.9 million in Q2 2026, while basic EPS has increased from US$3.52 to US$11.64 over the same period. This sets up a story in which strong reported margins are heavily shaped by a US$1.1 billion one off gain that investors will treat with caution.

See our full analysis for Roper Technologies.

With the latest numbers on the table, the next step is to see how this earnings profile lines up with the main narratives around Roper Technologies, and where those narratives might need to be updated.

See what the community is saying about Roper Technologies

NasdaqGS:ROP Revenue & Expenses Breakdown as at Jul 2026
NasdaqGS:ROP Revenue & Expenses Breakdown as at Jul 2026
Advertisement

Margins Jump to 30.2% on US$1.1b Gain

  • Roper Technologies reported a trailing 12 month net margin of 30.2% on US$8.3 billion of revenue and US$2.5 billion of net income, compared with 20.6% a year earlier. That step up is heavily shaped by a US$1.1 billion one off gain in the last year.
  • What stands out for the bearish narrative is the concern that this one time US$1.1 billion gain makes the 62.7% trailing earnings growth look less repeatable, even though:
    • Quarterly net income excluding extra items moved from US$378.3 million in Q2 2025 to US$1.2 billion in Q2 2026. This is a very large jump relative to the underlying trend across prior quarters.
    • Trailing 12 month EPS rose from US$14.3 to US$23.9 between Q4 2025 and Q2 2026, so a meaningful part of that uplift is tied to the gain rather than a steady climb in the quarterly numbers.
For readers worried that bears might be overstating the risk from that one off gain, it is worth seeing how they build their full case across Roper Technologies' acquisitions, AI rollout and end market exposure before deciding which parts feel most convincing to you. đŸ» Roper Technologies Bear Case

EPS Trend vs Forecast Earnings Decline

  • On a per share basis, quarterly basic EPS has moved from US$3.08 in Q1 2025 to US$11.64 in Q2 2026, while trailing 12 month EPS is US$23.90. Analysts as a group expect earnings to decline at about 6.8% per year over the next three years.
  • Analysts' consensus view is that this strong trailing EPS picture does not automatically translate into future growth, which creates a tension with the recent results because:
    • Trailing earnings growth of 62.7% and a margin profile at 30.2% are being compared against forecasts that assume profit margins ease from around 21.1% to 20.4% and earnings in 2029 of US$2.1 billion, rather than continuing at the recent pace.
    • The same consensus expects revenue to grow 8.5% annually. Revenue growth forecasts of 6.9% per year lag the broader US market at 12.7%, so the past year of strong profitability is set against more moderate top line expectations.

P/E Discount and DCF Gap for Roper Technologies

  • Roper Technologies trades on a trailing P/E of 14.5x at a share price of US$367.34. This sits below peers at around 30x, below the US Software industry on 27.8x, and below a DCF fair value of US$556.18, and both bulls and bears are weighing how much of that gap is justified.
  • Supporters of the bullish narrative point to this valuation gap as a potential opportunity, while the current forecasts introduce some friction with that view because:
    • The bullish case leans on revenue growth assumptions of 10.8% per year and a small margin lift to 21.2%. The risk summary highlights consensus expectations for earnings to decline 6.8% per year over the next three years, which is very different from that optimistic path.
    • Even with the DCF fair value at US$556.18 and an analyst target level of about US$439.12, the high level of debt and the influence of the US$1.1 billion one off gain on trailing results give investors concrete reasons to question how quickly the market might close that valuation gap.
If you want to see how bullish investors connect this valuation gap to AI driven growth, acquisitions and long term earnings potential at Roper Technologies, it is worth reading their thesis in full before you take a side. 🐂 Roper Technologies Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Roper Technologies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strong reported figures and one off gains at Roper Technologies leaves you unsure, act quickly by reviewing the data yourself, weighing both the concerns and the potential upside. Then check the 3 key rewards and 3 important warning signs

See What Else Is Out There

For Roper Technologies, the reliance on a US$1.1b one off gain, cautious earnings forecasts and concerns about debt all point to questions about resilience.

If you want more confidence that your next idea can better handle bumps in the road, check stocks with 81 resilient stocks with low risk scores and compare their risk profiles against Roper Technologies.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

‱ Dividend Powerhouses (3%+ Yield)
‱ Undervalued Small Caps with Insider Buying
‱ High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ROP

Roper Technologies

Designs and develops vertical software and technology enabled products in the United States, Canada, Europe, Asia, and internationally.

Undervalued with proven track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
37 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
59 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
21 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
19 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

AE
ASML logo
Aequitas on ASML Holding ·

ASML Will Reign as the Kingpin of the Semiconductor Supply Chain

Fair Value:€1.87k16.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AE
FTNT logo
Aequitas on Fortinet ·

Fortinet, compounding Cyber Security Player.

Fair Value:US$116.8430.4% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AE
CSU logo
Aequitas on Constellation Software ·

Constellation Software: A Proven Serial Acquirer at a Discount

Fair Value:CA$3.72k28.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
70 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
70 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TR
tripledub
GOOGL logo
tripledub on Alphabet ·

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.

Fair Value:US$23039.0% overvalued
92 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

0
|
0